Pubblicazioni

Risk factors for bone fractures in type 2 diabetes and the impact of once-weekly exenatide: insights from an EXSCEL post-hoc analysis

2025 - DIABETES RESEARCH AND CLINICAL PRACTICE
Maddaloni, Ernesto; Coleman, Ruth L.; Holman, Rury R.

The GLP-1 receptor agonists exenatide and liraglutide activate glucose transport by an AMPK-dependent mechanism

2016 - JOURNAL OF TRANSLATIONAL MEDICINE
Andreozzi, F; Raciti, Ga; Nigro, C; Mannino, Gc; Procopio, T; Davalli, Am; Beguinot, F; Sesti, G; Miele, C; Folli,

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma